180 filings
Page 3 of 9
8-K
6lqx 2mtlbe
21 May 21
Entry into a Material Definitive Agreement
4:52pm
8-K
mch0o4j jehvd06qu
17 May 21
Results of Operations and Financial Condition
7:05am
8-K
lka9rrchlzh0ou33wlcr
26 Apr 21
Entry into a Material Definitive Agreement
8:55am
8-K
ae7o 08zyi96iahwpsi
12 Apr 21
Regulation FD Disclosure
9:55am
8-K
9o9nqg6gvu8br5s6hy5q
30 Mar 21
Results of Operations and Financial Condition
7:40am
8-K
02u77b7qiho1mw
30 Mar 21
Entry into a Material Definitive Agreement
7:16am
8-K
eadgygqk hvva3vtw
25 Mar 21
Entry into a Material Definitive Agreement
8:51am
8-K
y9i 40g5n
15 Dec 20
Investor Presentation December 2020
8:35am
8-K
1l2xwqud0v
4 Nov 20
Results of Operations and Financial Condition
7:01am
8-K
1eria 6dilmwtr
21 Sep 20
PRS-343 Esmo Update September 2020
11:06am
8-K
srj54lzv
21 Sep 20
Regulation FD Disclosure
7:56am
8-K
nng9spb hq8xg
9 Sep 20
Investor Presentation September 2020
9:14am
8-K
6l7dmsetgzx k7eai
10 Aug 20
Pieris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:45am
8-K
0u1nghyat 4m
10 Aug 20
Entry into a Material Definitive Agreement
7:40am
8-K
tpn4x
20 Jul 20
Pieris Pharmaceuticals Announces Partial Clinical Hold on PRS-343
4:12pm
8-K
fgv16t1r5uygx owoxu
29 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
9a7adg29 1rf
8 Jun 20
Other Events
5:19pm
8-K
ceefts5 da3y5c
4 Jun 20
Investor Presentation June 2020
3:26pm
8-K
7oqej95o9fr qtenvi
21 May 20
Investor Presentation May 2020
10:10am
8-K
t3i7n
11 May 20
Results of Operations and Financial Condition
7:15am